imiquimod has been researched along with Encephalitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dembny, P; Derkow, K; Krüger, C; Lehnardt, S; Rosenberger, K; Schott, E | 1 |
| Chen, K; Cui, Y; Gong, W; Huang, J; Liu, Y; Wang, JM | 1 |
2 other study(ies) available for imiquimod and Encephalitis
| Article | Year |
|---|---|
The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration.
Topics: Aminoquinolines; Animals; Cells, Cultured; Chaperonin 60; Cytokines; Encephalitis; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Imiquimod; Lipopeptides; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neurodegenerative Diseases; Neurons; Nitric Oxide; Oligodeoxyribonucleotides; Phosphopyruvate Hydratase; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2014 |
Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells.
Topics: Adaptor Proteins, Vesicular Transport; Aminoquinolines; Animals; Cell Line; Drug Synergism; Encephalitis; Gliosis; I-kappa B Proteins; Imiquimod; MAP Kinase Signaling System; Membrane Glycoproteins; Mice; Microglia; Myeloid Differentiation Factor 88; NF-KappaB Inhibitor alpha; Phosphorylation; Poly I-C; Receptors, Formyl Peptide; RNA Virus Infections; Signal Transduction; Toll-Like Receptor 3; Toll-Like Receptor 7; Up-Regulation | 2009 |